AI assistant
Nuvalent, Inc. — Director's Dealing 2025
Oct 17, 2025
30903_dirs_2025-10-17_b427b25e-6de2-4ec4-89d4-97f8e17325c5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Nuvalent, Inc. (NUVL)
CIK: 0001861560
Period of Report: 2025-10-15
Reporting Person: Balcom Alexandra (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-10-15 | Class A Common Stock | M | 1683 | $18.93 | Acquired | 63417 | Direct |
| 2025-10-15 | Class A Common Stock | S | 1683 | $85.57 | Disposed | 61734 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-10-15 | Stock Option (Right to Buy) | $18.93 | M | 1683 | Disposed | 2032-01-04 | Class A Common Stock (1683) | Direct |
Footnotes
F1: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2024.
F2: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.00 to $85.69, inclusive. The reporting person undertakes to
provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold
at each separate price.
F3: The shares underlying this option vest as follows: 25% of the shares vested on January 4, 2023, and the remainder have vested or shall vest over the three years thereafter in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.